Exact Sciences' big week & more: 4 GI company key notes - Becker's ASC Review

Here are four updates from gastroenterology companies from the past week:

Exact Sciences posted second-quarter 2019 revenues of $199.9 million, a 94 percent year-over-year increase. Read more. The company also announced it will acquire diagnostic testing company Genomic Health in a $72 per share, $2.8 billion dollar deal. 

Jamison, Pa.-based Physicians Endoscopy President David Young offered Becker's ASC Review several insights into the company and its future. 

Bausch Health, formerly known as Valeant Pharmaceuticals, reduced its debt further, paying down an additional $100 million in senior secured term loans through cash flow.

Evanston-based Illinois Gastroenterology Group closed a private equity deal joining the GI Alliance, which created the largest independent gastroenterology services organization in the nation.

More articles on surgery centers: 
Looser ASC requirements, 24-hour stays & more: 3 regulation updates to know
Becoming an administrator & what separates ASCs from one another — 2 insights from a recruiter
Hospital-owned ASC doesn't get tax exemption, Pennsylvania court says 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.



https://ift.tt/2LSe138

Comments

Popular posts from this blog

Strays welcome - Ways you can reach out to help lonely and neglected animals

Best Pet Insurance Companies & Plans 2024 | U.S. News

Binghamton Plaza Shop Owners Concerned About Eminent Domain ...